{"id":694827,"date":"2024-08-23T15:55:29","date_gmt":"2024-08-23T13:55:29","guid":{"rendered":"https:\/\/www.hashtag.al\/?p=694827"},"modified":"2024-08-23T15:55:29","modified_gmt":"2024-08-23T13:55:29","slug":"nis-testimi-i-vaksines-se-pare-ne-bote-mrna-kunder-kancerit-te-mushkerive","status":"publish","type":"post","link":"https:\/\/www.hashtag.al\/index.php\/2024\/08\/23\/nis-testimi-i-vaksines-se-pare-ne-bote-mrna-kunder-kancerit-te-mushkerive\/","title":{"rendered":"Nis testimi i vaksin\u00ebs s\u00eb par\u00eb n\u00eb bot\u00eb mRNA kund\u00ebr kancerit t\u00eb mushk\u00ebrive","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"

\"\"<\/a><\/span><\/p>\n

Mjek\u00ebt kan\u00eb nisur prov\u00ebn e vaksin\u00ebs s\u00eb par\u00eb mRNA n\u00eb bot\u00eb kund\u00ebr kancerit t\u00eb mushk\u00ebrive n\u00eb shtat\u00eb vende, p\u00ebrfshir\u00eb T\u00fcrkiyen, n\u00eb nj\u00eb p\u00ebrpjekje novatore q\u00eb mund t\u00eb revolucionarizoj\u00eb trajtimin e kancerit, transmeton Anadolu.<\/a><\/span><\/span><\/p>\n

Vaksina, e njohur si BNT116 dhe e zhvilluar nga BioNTech, \u00ebsht\u00eb krijuar p\u00ebr t\u00eb synuar kancerin e mushk\u00ebrive me qeliza jo t\u00eb vogla (NSCLC), lloji m\u00eb i zakonsh\u00ebm i kancerit t\u00eb mushk\u00ebrive. Ai synon t\u00eb eliminoj\u00eb qelizat e kancerit dhe t\u00eb parandaloj\u00eb p\u00ebrs\u00ebritjen e tyre duke trajnuar sistemin imunitar p\u00ebr t\u00eb njohur dhe sulmuar marker\u00ebt e tumorit specifik p\u00ebr NSCLC.<\/span><\/p>\n

Testimi, q\u00eb zhvillohet n\u00eb Britani, SHBA, Gjermani, Spanj\u00eb dhe T\u00fcrkiye, nd\u00ebr t\u00eb tjera, konsiderohet si nj\u00eb hap i r\u00ebnd\u00ebsish\u00ebm n\u00eb trajtimin e kancerit t\u00eb mushk\u00ebrive. Kanceri i mushk\u00ebrive mbetet shkaku kryesor i vdekjeve nga kanceri n\u00eb mbar\u00eb bot\u00ebn, p\u00ebrgjegj\u00ebs p\u00ebr rreth 1,8 milion vdekje n\u00eb vit, me norma ve\u00e7an\u00ebrisht t\u00eb ul\u00ebta t\u00eb mbijetes\u00ebs te rastet e avancuara.<\/span><\/p>\n

Prova klinike e faz\u00ebs 1 po kryhet n\u00eb 34 lokacione k\u00ebrkimore, duke p\u00ebrfshir\u00eb gjasht\u00eb n\u00eb Britani. Pacienti i par\u00eb n\u00eb Mbret\u00ebrin\u00eb e Bashkuar mori vaksin\u00ebn t\u00eb mart\u00ebn, duke sh\u00ebnuar nj\u00eb moment historik kritik n\u00eb studim, tha gazeta Guardian.<\/span><\/p>\n

Rreth 130 pacient\u00eb me stade t\u00eb ndryshme t\u00eb kancerit t\u00eb mushk\u00ebrive, nga faza e hershme n\u00eb t\u00eb avancuar ose t\u00eb p\u00ebrs\u00ebritur, do t\u00eb marrin pjes\u00eb n\u00eb prov\u00eb, duke marr\u00eb vaksin\u00ebn s\u00eb bashku me imunoterapin\u00eb. Teknologjia mRNA e p\u00ebrdorur n\u00eb BNT116 \u00ebsht\u00eb e ngjashme me at\u00eb n\u00eb vaksinat kund\u00ebr COVID-19, duke punuar duke nxitur sistemin imunitar t\u00eb sulmoj\u00eb qelizat e kancerit dhe duke i kursyer ato t\u00eb sh\u00ebndetshme, ndryshe nga kimioterapia tradicionale.<\/span><\/p>\n

Si\u00e7 raportohet nga Guardian, ekspert\u00ebt, duke p\u00ebrfshir\u00eb Siow Ming Lee nga Spitalet e Universitetit College London, e shohin k\u00ebt\u00eb prov\u00eb si fillimin e nj\u00eb “epoke t\u00eb re shum\u00eb emocionuese” n\u00eb k\u00ebrkimet mbi kancerin.<\/span><\/p>\n

Nj\u00eb nga pjes\u00ebmarr\u00ebsit e par\u00eb, shkenc\u00ebtari 67-vje\u00e7ar Janusz Racz nga Londra, iu bashkua testimit p\u00ebr shkak t\u00eb besimit t\u00eb tij n\u00eb p\u00ebrparimin e shkenc\u00ebs. I diagnostikuar n\u00eb maj, Racz shpreson se trajtimi i ri do t\u00eb ndihmoj\u00eb n\u00eb eliminimin e kancerit t\u00eb tij dhe do t\u00eb kontribuoj\u00eb n\u00eb p\u00ebrpjekjet globale p\u00ebr t\u00eb zhvilluar terapi efektive t\u00eb kancerit. Ai do t\u2019i n\u00ebnshtrohet nj\u00eb regjimi rigoroz t\u00eb trajtimit, duke p\u00ebrfshir\u00eb injeksione t\u00eb shumta \u00e7do jav\u00eb, t\u00eb ndjekur nga doza periodike gjat\u00eb nj\u00eb viti.<\/span><\/p>\n

Nd\u00ebrsa prova p\u00ebrparon, studiuesit synojn\u00eb t\u00eb demonstrojn\u00eb efektivitetin e vaksin\u00ebs n\u00eb parandalimin e p\u00ebrs\u00ebritjes s\u00eb kancerit t\u00eb mushk\u00ebrive, duke e b\u00ebr\u00eb at\u00eb nj\u00eb trajtim standard n\u00eb mbar\u00eb bot\u00ebn.<\/span><\/p>\n

Kjo iniciativ\u00eb \u00ebsht\u00eb pjes\u00eb e nj\u00eb skeme m\u00eb t\u00eb gjer\u00eb t\u00eb Sh\u00ebrbimit Komb\u00ebtar t\u00eb Sh\u00ebndetit (NHS) p\u00ebr t\u00eb p\u00ebrshpejtuar pacient\u00ebt n\u00eb provat klinike p\u00ebr trajtime inovative t\u00eb kancerit, e cila \u00ebsht\u00eb p\u00ebrsh\u00ebndetur si nj\u00eb ndryshim potencial i rrjedh\u00ebs n\u00eb luft\u00ebn kund\u00ebr kancerit t\u00eb mushk\u00ebrive.<\/span><\/p>\n

Ministri i Shkenc\u00ebs i Mbret\u00ebris\u00eb s\u00eb Bashkuar, Lord Vallance, ka shprehur optimiz\u00ebm p\u00ebr k\u00ebt\u00eb testim, duke theksuar potencialin e vaksin\u00ebs p\u00ebr t\u00eb shp\u00ebtuar mij\u00ebra jet\u00eb, tha Guardian.<\/span><\/p>\n

Nd\u00ebrkoh\u00eb, Racz mbetet me shpres\u00eb se pas p\u00ebrfundimit t\u00eb trajtimit, ai mund t\u2019i rikthehet vrapimit dhe t\u00eb arrij\u00eb q\u00ebllimin e tij p\u00ebr t\u00eb p\u00ebrfunduar Maraton\u00ebn e Londr\u00ebs.<\/span><\/p>\n

Ky test p\u00ebrfaq\u00ebson nj\u00eb moment historik t\u00eb r\u00ebnd\u00ebsish\u00ebm n\u00eb k\u00ebrkimin e kancerit t\u00eb mushk\u00ebrive, me potencialin p\u00ebr t\u00eb transformuar rezultatet e trajtimit dhe p\u00ebr t\u00eb ofruar shpres\u00eb t\u00eb re p\u00ebr pacient\u00ebt n\u00eb mbar\u00eb bot\u00ebn.<\/span><\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"

Mjek\u00ebt kan\u00eb nisur prov\u00ebn e vaksin\u00ebs s\u00eb par\u00eb mRNA n\u00eb bot\u00eb kund\u00ebr kancerit t\u00eb mushk\u00ebrive n\u00eb shtat\u00eb vende, p\u00ebrfshir\u00eb T\u00fcrkiyen, n\u00eb nj\u00eb p\u00ebrpjekje novatore q\u00eb mund t\u00eb revolucionarizoj\u00eb trajtimin e kancerit, transmeton Anadolu. Vaksina, e njohur si BNT116 dhe e zhvilluar nga BioNTech, \u00ebsht\u00eb krijuar p\u00ebr t\u00eb synuar kancerin e mushk\u00ebrive me qeliza jo t\u00eb […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":32,"featured_media":694828,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53],"tags":[],"class_list":["post-694827","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fast-foodi"],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts\/694827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/comments?post=694827"}],"version-history":[{"count":0,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts\/694827\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/media\/694828"}],"wp:attachment":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/media?parent=694827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/categories?post=694827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/tags?post=694827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}